Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Revenue

Avalo Therapeutics had revenue of $441.00K in the twelve months ending June 30, 2025, down -45.35% year-over-year. In the year 2024, Avalo Therapeutics had annual revenue of $441.00K, down -77.08%.

• Revenue (ttm): $441.00K
• Revenue Growth: -45.35%
• P/S Ratio: 191.16
• Revenue / Employee: $19,174
• Employees: 23
• Market Cap: 119.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	441.00K	-1.48M	-77.08%
Dec 31, 2023	1.92M	-16.13M	-89.34%
Dec 31, 2022	18.05M	12.65M	234.40%
Dec 31, 2021	5.40M	-1.30M	-19.42%
Dec 31, 2020	6.70M	-51.35K	-0.76%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.